View up-to-date information on Kiniksa Pharmaceuticals Ltd patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US20220281914A1 | Application | PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME | B01D15/327; B01D15/3809; C07K1/18; C07K1/22; C07K1/36 | September 08, 2022 |
AU2016315873B2 | Grant | Humanized anti-CD40 antibodies and uses thereof | A61K2039/505; A61K2300/00; A61K31/436; A61K38/00; A61K39/395; A61K39/3955; A61K39/39558; A61K45/06; A61P29/00; A61P35/00; A61P37/00; A61P37/06; C07K16/18; C07K16/2866; C07K16/2878; C07K2317/24; C07K2317/33; C07K2317/76; C07K2317/92; C07K2317/94; Y02A50/30 | August 18, 2022 |
WO2022133191A3 | Application | PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME | B01D15/327; B01D15/3809; C07K1/18; C07K1/22; C07K1/36; C07K16/065; C07K16/2866; C07K2317/21 | July 28, 2022 |
NZ753995A | Application | Oncostatin m receptor antigen binding proteins | A61K39/395; A61K39/39533; A61P1/16; A61P1/18; A61P11/00; A61P17/00; A61P17/04; A61P17/06; A61P19/00; A61P19/02; A61P25/04; A61P29/00; A61P37/02; A61P37/06; A61P37/08; A61P43/00; C07K16/244; C07K16/248; C07K16/28; C07K16/2866; C07K2317/21; C07K2317/515; C07K2317/56; C07K2317/565; C07K2317/76; C07K2317/92 | July 01, 2022 |
NZ713636A | Application | Oncostatin m receptor antigen binding proteins | A61K39/395; A61K39/39533; A61P1/16; A61P1/18; A61P11/00; A61P17/00; A61P17/04; A61P17/06; A61P19/00; A61P19/02; A61P25/04; A61P29/00; A61P37/02; A61P37/06; A61P37/08; A61P43/00; C07K16/244; C07K16/248; C07K16/28; C07K16/2866; C07K2317/21; C07K2317/515; C07K2317/56; C07K2317/565; C07K2317/76; C07K2317/92 | July 01, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer